Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,870 | 1,020 | 99.7% |
| Education | $47.40 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,813 | 149 | $0 (2022) |
| PFIZER INC. | $1,926 | 141 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,508 | 81 | $0 (2022) |
| Novo Nordisk Inc | $1,495 | 93 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $934.09 | 66 | $0 (2024) |
| Merck Sharp & Dohme LLC | $860.37 | 77 | $0 (2022) |
| Amarin Pharma Inc. | $711.54 | 32 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $664.19 | 42 | $0 (2022) |
| Lilly USA, LLC | $511.09 | 59 | $0 (2023) |
| Astellas Pharma US Inc | $482.31 | 32 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.16 | 7 | Daiichi Sankyo Inc. ($33.35) |
| 2023 | $497.39 | 10 | Inspire Medical Systems, Inc. ($135.04) |
| 2022 | $354.26 | 15 | AstraZeneca Pharmaceuticals LP ($120.17) |
| 2021 | $371.33 | 24 | Novo Nordisk Inc ($69.51) |
| 2020 | $2,337 | 141 | AstraZeneca Pharmaceuticals LP ($502.69) |
| 2019 | $4,172 | 261 | AstraZeneca Pharmaceuticals LP ($744.98) |
| 2018 | $4,101 | 277 | PFIZER INC. ($739.87) |
| 2017 | $3,931 | 290 | AstraZeneca Pharmaceuticals LP ($708.82) |
All Payment Transactions
1,025 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Immunology | ||||||
| 01/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/21/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Endocrinology | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 11/08/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 10/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $121.45 | General |
| Category: Diabetes Care | ||||||
| 09/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $135.04 | General |
| Category: NEUROLOGY | ||||||
| 08/31/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Endocrinology | ||||||
| 07/21/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/09/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/24/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $93.09 | General |
| Category: Diabetes | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $95.38 | General |
| Category: Respiratory | ||||||
| 09/26/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ANTIBIOTICS | ||||||
| 09/01/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Immunology | ||||||
| 08/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Gastroenterology | ||||||
| 08/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Cardio-renal | ||||||
| 07/19/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 07/19/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 27 | 48 | $3,240 | $2,508 |
| 2021 | 2 | 23 | 56 | $4,446 | $3,620 |
| 2020 | 19 | 1,618 | 3,397 | $318,406 | $130,741 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 48 | $3,240 | $2,508 | 77.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 34 | $3,060 | $2,492 | 81.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 22 | $1,386 | $1,129 | 81.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 659 | 1,887 | $196,402 | $79,646 | 40.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 357 | 574 | $84,660 | $32,609 | 38.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 22 | 23 | $4,795 | $3,243 | 67.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 16 | 16 | $4,364 | $2,988 | 68.5% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 221 | 502 | $7,530 | $1,880 | 25.0% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 31 | 54 | $3,240 | $1,669 | 51.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $1,820 | $1,553 | 85.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $4,175 | $1,500 | 35.9% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 33 | 34 | $2,380 | $1,374 | 57.7% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 21 | $1,107 | $1,032 | 93.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $1,760 | $752.05 | 42.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 16 | 16 | $1,360 | $498.50 | 36.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 17 | $1,098 | $480.22 | 43.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 27 | 27 | $675.00 | $420.07 | 62.2% |
| 80305 | Testing for presence of drug | Office | 2020 | 32 | 32 | $640.00 | $372.15 | 58.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 30 | 49 | $1,330 | $324.68 | 24.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 54 | 62 | $620.00 | $213.31 | 34.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 15 | $300.00 | $128.40 | 42.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 19 | 20 | $150.00 | $58.05 | 38.7% |
About Dr. Eric Hemberg, MD
Dr. Eric Hemberg, MD is a Family Medicine healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992738926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Hemberg, MD has received a total of $15,917 in payments from pharmaceutical and medical device companies, with $153.16 received in 2024. These payments were reported across 1,025 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($15,870).
As a Medicare-enrolled provider, Hemberg has provided services to 1,668 Medicare beneficiaries, totaling 3,501 services with total Medicare billing of $136,869. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Opelika, AL
- Active Since 07/10/2006
- Last Updated 07/16/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992738926
Products in Payments
- FARXIGA (Drug) $1,622
- TRELEGY ELLIPTA (Drug) $902.99
- ELIQUIS (Drug) $742.57
- Vascepa (Drug) $711.54
- JARDIANCE (Drug) $645.15
- Ozempic (Drug) $565.00
- JANUVIA (Drug) $544.21
- XARELTO (Drug) $484.00
- Victoza (Drug) $459.51
- SYMBICORT (Drug) $427.37
- Trintellix (Drug) $369.19
- LYRICA (Drug) $358.87
- CHANTIX (Drug) $352.87
- BEVESPI AEROSPHERE (Drug) $335.82
- Tresiba (Drug) $311.05
- ENTRESTO (Drug) $295.76
- ANORO (Drug) $293.97
- MYRBETRIQ (Drug) $288.69
- APTIOM (Drug) $211.92
- Creon (Drug) $196.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Opelika
Dr. Sunil Sharma, Md, MD
Family Medicine — Payments: $22,963
Dr. Keith Fuller, D.o, D.O
Family Medicine — Payments: $12,787
Dr. Brian Rogers, M.d, M.D
Family Medicine — Payments: $7,490
Sara Norris, Crnp, CRNP
Family Medicine — Payments: $6,666
Dr. John Cooper, M.d, M.D
Family Medicine — Payments: $5,864
Dr. Hiren Patel, M.d, M.D
Family Medicine — Payments: $3,763